WhatsApp
backNews Article

Emcure Pharmaceuticals to Attend JM Financial India Xchange 2026 Investor Meeting in Mumbai on November 16

Company officials will participate physically without sharing any unpublished price sensitive information, confirming compliance with SEBI regulations

Emcure Pharmaceuticals Limited announced its planned participation in the JM Financial Annual India Xchange 2026 investor meeting scheduled for November 16, 2026, in Mumbai. The company confirmed that no unpublished price sensitive information will be shared during this physical event.

06 Nov 2026|EMCURE+0.70%
Emcure Pharmaceuticals LimitedEMCUREInvestor Presentation

Emcure Pharmaceuticals Limited

Investor Presentation

Emcure Pharmaceuticals Limited has scheduled its officials to attend the JM Financial Annual India Xchange 2026 investor meeting on November 16, 2026, in Mumbai. The meeting will be held physically and no unpublished price sensitive information is planned to be discussed.

The investor meeting is part of the company’s engagement with analysts and investors to provide insights into its operational and financial status.

Emcure Pharmaceuticals emphasized that the schedule is tentative and subject to change due to exigencies from either the investors or the company.

The company confirmed adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring no undisclosed price sensitive information will be shared during the meeting.

This announcement was made public on November 6, 2026, to keep investors and stakeholders informed about upcoming company interactions.

Highlights

  • Scheduled meeting: JM Financial Annual India Xchange 2026
  • Date: Monday, November 16, 2026
  • Location: Mumbai
  • Mode: Physical meeting
  • No unpublished price sensitive information to be shared
  • Subject to change based on exigencies

Key Data Snapshot

Event NameJM Financial Annual India Xchange 2026
Meeting DateNovember 16, 2026
Meeting LocationMumbai
Meeting ModePhysical
Price Sensitive Information StatusNo unpublished information to be shared

What happened

  • Emcure Pharmaceuticals scheduled its participation in an investor meeting hosted by JM Financial.
  • The event is slated for November 16, 2026, in Mumbai and will be held physically.
  • The company stated that no unpublished price sensitive information will be discussed during the meeting.

Regulatory and governance context

  • The disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The schedule disclosed is tentative and may change due to exigencies from investors or the company.

More News on Investor Presentation

View all

Latest corporate announcements and market updates in Investor Presentation.

View all news
Emcure Pharmaceuticals to Attend JM Financial India | Stockk News